NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 272 filers reported holding NEOGENOMICS INC in Q1 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,085,856 | -27.5% | 88,281 | -5.2% | 0.00% | -33.3% |
| Q2 2023 | $1,496,757 | -23.8% | 93,140 | -17.4% | 0.00% | -25.0% |
| Q1 2023 | $1,963,636 | +393.5% | 112,788 | +161.9% | 0.00% | +300.0% |
| Q4 2022 | $397,926 | -27.4% | 43,066 | -32.4% | 0.00% | 0.0% |
| Q3 2022 | $548,000 | +1.7% | 63,719 | -3.7% | 0.00% | 0.0% |
| Q2 2022 | $539,000 | -79.1% | 66,149 | -68.8% | 0.00% | -80.0% |
| Q1 2022 | $2,574,000 | -73.9% | 211,877 | -26.7% | 0.01% | -72.2% |
| Q4 2021 | $9,856,000 | -3.5% | 288,883 | +36.4% | 0.02% | -14.3% |
| Q3 2021 | $10,216,000 | +156.9% | 211,758 | +140.6% | 0.02% | +133.3% |
| Q2 2021 | $3,976,000 | -21.5% | 88,024 | -14.0% | 0.01% | -30.8% |
| Q1 2021 | $5,064,000 | -15.0% | 102,407 | -7.5% | 0.01% | -13.3% |
| Q4 2020 | $5,961,000 | +90.3% | 110,714 | +30.4% | 0.02% | +66.7% |
| Q3 2020 | $3,132,000 | +18.1% | 84,892 | -0.9% | 0.01% | +12.5% |
| Q2 2020 | $2,653,000 | -8.5% | 85,651 | -18.5% | 0.01% | -27.3% |
| Q1 2020 | $2,900,000 | +109.4% | 105,052 | +121.4% | 0.01% | +175.0% |
| Q4 2019 | $1,385,000 | +175.9% | 47,447 | +80.4% | 0.00% | +300.0% |
| Q3 2019 | $502,000 | -62.5% | 26,305 | -56.8% | 0.00% | -75.0% |
| Q2 2019 | $1,338,000 | -12.4% | 60,921 | -18.5% | 0.00% | -20.0% |
| Q1 2019 | $1,528,000 | +74.6% | 74,730 | +9.9% | 0.01% | +66.7% |
| Q4 2018 | $875,000 | +507.6% | 67,990 | +630.0% | 0.00% | +200.0% |
| Q3 2018 | $144,000 | -81.1% | 9,314 | -84.0% | 0.00% | -66.7% |
| Q2 2018 | $762,000 | +90.0% | 58,141 | +18.4% | 0.00% | +50.0% |
| Q1 2018 | $401,000 | +33.2% | 49,115 | +44.8% | 0.00% | +100.0% |
| Q4 2017 | $301,000 | -27.1% | 33,923 | -8.6% | 0.00% | 0.0% |
| Q3 2017 | $413,000 | +525.8% | 37,121 | +402.4% | 0.00% | – |
| Q2 2017 | $66,000 | +46.7% | 7,389 | +30.4% | 0.00% | – |
| Q1 2017 | $45,000 | -8.2% | 5,667 | -0.0% | 0.00% | – |
| Q4 2016 | $49,000 | +6.5% | 5,668 | +0.7% | 0.00% | – |
| Q3 2016 | $46,000 | +48.4% | 5,631 | +48.1% | 0.00% | – |
| Q2 2016 | $31,000 | +210.0% | 3,801 | +160.7% | 0.00% | – |
| Q1 2016 | $10,000 | +233.3% | 1,458 | +264.5% | 0.00% | – |
| Q4 2015 | $3,000 | -99.5% | 400 | -99.6% | 0.00% | -100.0% |
| Q3 2015 | $607,000 | – | 105,960 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |